triazoles has been researched along with Lupus Erythematosus, Systemic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, M; Bubb, M; Chaichian, Y; Chatham, W; Derebail, V; Genovese, M; Gurtovaya, O; Hajian, H; Lim, S; Patel, U; Rao, P; Tumlin, J | 1 |
| Gao, K; Gao, X; Wu, J; Zhao, M | 1 |
| Hachulla, E; Kahl, L; Layton, M; Machado, D; Patel, J; Schifano, L; Staumont-Sallé, D; van Vollenhoven, RF | 1 |
| Bates, RC; Chu, J; Huang, Q; Inoue, T; Liu, Y; Rao, PE; Shin Ogawa, L; Sonderfan, AJ; Ye, J; Ying, W; Zhou, D | 1 |
| Astakhova, K; Macaubas, C; Maity, A; Mellins, E | 1 |
| Sha, H; Sun, Y; Wei, S | 1 |
| Binks, M; Condreay, L; Dickson, M; Hachulla, E; Hicks, K; Kahl, L; Layton, M; Leon, G; Machado, D; Patel, J; Schifano, L; Staumont-Sallé, D; van Vollenhoven, RF; Zamuner, S | 1 |
| Espinosa, G; Gállego, M; Gascón, J; López-Chejade, PL; Pinazo, MJ; Urbina, JA | 1 |
| Clayton, J | 1 |
| Putterman, C; Tagoe, C | 1 |
| Al-Tawfiq, JA; Amr, SS | 1 |
| Begueret, H; Beylot-Barry, M; Couprie, B; Domergue, V; Doutre, MS; Huerre, M; Orlandini, V; Tunon de Lara, M | 1 |
| Buising, K; Daffy, J; Peel, T; Stanley, P; Thursky, K | 1 |
3 trial(s) available for triazoles and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy.
Topics: Glomerulonephritis, Membranous; Humans; Lupus Erythematosus, Systemic; Pyridines; Triazoles | 2020 |
DRESS syndrome and reversible liver function abnormalities in patients with systemic lupus erythematosus treated with the highly selective JAK-1 inhibitor GSK2586184.
Topics: Adult; Azetidines; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity Syndrome; Female; Humans; Janus Kinase 1; Lupus Erythematosus, Systemic; Middle Aged; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Triazoles | 2015 |
Safety, tolerability, efficacy and pharmacodynamics of the selective JAK1 inhibitor GSK2586184 in patients with systemic lupus erythematosus.
Topics: Administration, Oral; Adult; Azetidines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Interferons; Janus Kinase 1; Lupus Erythematosus, Systemic; Male; Middle Aged; Treatment Failure; Treatment Outcome; Triazoles; Young Adult | 2016 |
10 other study(ies) available for triazoles and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
[Effect of JQ1 on expression of autoimmune-related genes in CD4+T cells of systemic lupus erythematosus].
Topics: Azepines; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cytokines; Flow Cytometry; Humans; Interferon-gamma; Lupus Erythematosus, Systemic; Proteins; RNA, Messenger; Time Factors; Transforming Growth Factor beta1; Triazoles | 2018 |
The HSP90 Inhibitor Ganetespib Alleviates Disease Progression and Augments Intermittent Cyclophosphamide Therapy in the MRL/lpr Mouse Model of Systemic Lupus Erythematosus.
Topics: Animals; B-Lymphocytes; Cyclophosphamide; Cytokines; Disease Models, Animal; Disease Progression; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Mice; Spleen; T-Lymphocytes; Triazoles | 2015 |
Synthesis of Phospholipid-Protein Conjugates as New Antigens for Autoimmune Antibodies.
Topics: Alkynes; Antigen-Antibody Complex; Antigens; Antiphospholipid Syndrome; Autoantibodies; Azides; beta 2-Glycoprotein I; Click Chemistry; Cycloaddition Reaction; Ethanolamines; Humans; Immunoconjugates; Lupus Erythematosus, Systemic; Protein Binding; Prothrombin; Solutions; Triazoles | 2015 |
Therapeutic targeting of BET protein BRD4 delays murine lupus.
Topics: Animals; Azepines; Disease Progression; DNA; Humans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Monocytes; Nerve Tissue Proteins; Nuclear Proteins; Proteinuria; Receptors, Cell Surface; Spleen; Tetrazolium Salts; Thiazoles; Transcription Factors; Triazoles | 2015 |
Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus.
Topics: Adult; Chagas Disease; Female; Humans; Lupus Erythematosus, Systemic; Triazoles; Trypanocidal Agents | 2010 |
Chagas disease: pushing through the pipeline.
Topics: Adult; Animals; Chagas Disease; Child; Chronic Disease; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Humans; Infant, Newborn; Lupus Erythematosus, Systemic; Molecular Targeted Therapy; Nitroimidazoles; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2010 |
JAK2 inhibition in murine systemic lupus erythematosus.
Topics: Animals; Disease Models, Animal; Humans; Interleukin-6; Janus Kinase 2; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Plasma Cells; Pyridines; Signal Transduction; Treatment Outcome; Triazoles | 2012 |
Aspiration cytology of brain abscess from a fatal case of cerebral phaeohyphomycosis due to Ramichloridium mackenziei.
Topics: Aged; Amphotericin B; Antifungal Agents; Ascomycota; Biopsy, Needle; Brain Abscess; Central Nervous System Fungal Infections; Combined Modality Therapy; Diabetes Complications; Diabetes Mellitus; Fatal Outcome; Female; Humans; Lupus Erythematosus, Systemic; Pyrimidines; Triazoles; Voriconazole | 2007 |
[Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Bone Diseases, Infectious; Caspofungin; Echinocandins; Humans; Lipopeptides; Lung; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Male; Pyrimidines; Skin; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Posaconazole as first line treatment for disseminated zygomycosis.
Topics: Antifungal Agents; Female; Hip Prosthesis; Humans; Immunocompromised Host; Lung Diseases, Fungal; Lupus Erythematosus, Systemic; Middle Aged; Prosthesis-Related Infections; Rhizopus; Triazoles; Zygomycosis | 2008 |